MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
MEGIN Matters July 2025

MEGIN Matters July 2025

by Naomi Devlin | Jul 29, 2025 | MEGIN Matters

Typing With the Mind: Inside the Future of Brain Computer Interfaces – Featuring Dr Svetlana Pinet

Typing With the Mind: Inside the Future of Brain Computer Interfaces – Featuring Dr Svetlana Pinet

by Naomi Devlin | Jul 15, 2025 | Spotlights - Translational Research

MEGIN Spotlights Typing With the Mind: Inside the Future of Brain Computer Interfaces – Featuring Dr Svetlana Pinet   Hosted by Nicole Sourry, Associate Director, Global Marketing and Sales at MEGIN. Dr. Svetlana Pinet explains how MEG and AI are unlocking the...
MEGIN Matters June 2025

MEGIN Matters June 2025

by Naomi Devlin | Jun 25, 2025 | MEGIN Matters

Empowering Families Through Pediatric Epilepsy Surgery – Featuring Monika Jones 

Empowering Families Through Pediatric Epilepsy Surgery – Featuring Monika Jones 

by Naomi Devlin | Jun 24, 2025 | Spotlights - Caregiver Perspective, Spotlights - Clinical MEG

MEGIN Spotlights Empowering Families Through Pediatric Epilepsy Surgery – Featuring Monika Jones   Hosted by Gabriele Richardson, Director, Global Sales and Marketing at MEGIN.  In this inspiring episode of the MEGIN Spotlights, we speak with Monika Jones, CEO...
MEG to gain insight into Parkinson’s disease and its treatment

MEG to gain insight into Parkinson’s disease and its treatment

by Naomi Devlin | Jun 19, 2025 | Masterclass - Translational Research

MEGIN Masterclass MEG to gain insight into Parkinson’s disease and its treatment Presented by Esther Florin, Lichtenburg Professor for Systems Neuroscience. Abstract: “Deep Brain Stimulation (DBS) is an invasive treatment option for neurological and psychiatric...
« Older Entries
Next Entries »

Home
About us

MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.